FDA broadens use of Novartis’ radiopharma drug Pluvicto

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients who are eligible for treatment.

Mar 28, 2025 - 22:34
 0
FDA broadens use of Novartis’ radiopharma drug Pluvicto

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients who are eligible for treatment.